SCYNEXIS Presents Data at Superbugs and Superdrugs 2018

Mar 20, 2018

SCYNEXIS Reports Full Year 2017 Financial Results and Provides Company Update

Mar 13, 2018

SCYNEXIS to Present at the 30th Annual ROTH Conference

Mar 7, 2018

SCYNEXIS Announces Pricing of $30.0 Million Public Offering of Common Stock and Warrants

Mar 6, 2018

SCYNEXIS Announces Launch of Public Offering of Common Stock and Warrants

Mar 5, 2018

SCYNEXIS Presents New In Vivo Data Highlighting the Potential of SCY-078 Used in Combination for the Treatment of Aspergillus Infections at AAA 2018

Feb 1, 2018

SCYNEXIS Provides Corporate and SCY-078 Pipeline Update

Jan 4, 2018

SCYNEXIS to Participate in Upcoming Investor Conferences

Nov 28, 2017

SCYNEXIS to Present at the 29th Annual Piper Jaffray Healthcare Conference

Nov 22, 2017

SCYNEXIS Appoints Scott Sukenick as General Counsel

Nov 16, 2017